Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare ...

BRINP2-related peptide, or BRP, is a naturally occurring molecule that can suppress appetite and promote weight loss in mice ...

A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG, which makes pens used to ...

Novo Nordisk is cutting the price of its weight-loss drug, Wegovy, and selling it through a direct-to-patient online pharmacy ...

a 56% increase over sales in the prior year. The vast majority of that revenue came from Wegovy. The pharma giant wants to protect that revenue from competitors. Its new Wegovy offering is the ...

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients ...

A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...

The offer may show employers how hard drug manufacturers will compete based on price, in at least some situations.

The top 10 projected best-selling medications in 2026, including GLP-1 drugs and AbbVie's Skyrizi, have expected global sales reaching up to $31 billiion.

In context, Wegovy sales jumped over 100% year-over-year to DKK.19.87 billion in Q4 FY24. For the full year, sales rose 56% to DKK.65.1 billion in FY24, particularly due to high demand in the U.S ...

Hims & Hers Health (NYSE:HIMS) shares were on a massive run, but that momentum hit a wall recently. Since its peak on ...